Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (364)
  2. Journal Article (358)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (790)
  2. Department of Medicine (790)
  3. Gastrointestinal Oncology Service (790)
  4. Solid Tumor Oncology Division (790)
  5. Epidemiology and Biostatistics (178)
  6. Surgery (168)

More Groups

People
  1. Ghassan Abou-Alfa (156)
  2. Kenneth Yu (121)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (94)
  6. William Jarnagin (84)

More People

Years
  1. 2025 (38)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (294)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (308)
  2. Oxford University Press (71)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (790)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors
    Meeting Abstract

    Ahnert, J. R.; Taylor, M. H.; O'Reilly, E. M.; Zhang, J.; Doebele, R. C.; Ben, Y.; Sharp, L. L.; Boyle, W. J.; Chang, C.; Frey, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Qualitative study of cancer patients' advance care planning (ACP) values
    Meeting Abstract

    Agarwal, R.; Volandes, A. E.; Romano, D. R.; Genoff, M.; O'Reilly, E. M.; Breitbart, W.; Epstein, A. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB80802 (Alliance) (C8)
    Meeting Abstract

    Abou-Alfa, G. K.; Shi, Q.; Knox, J. J.; Kaubisch, A.; Posey, J.; Tan, B. R.; Kavan, P.; Goel, R.; Lammers, P. E.; Bekaii-Saab, T. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A randomized phase 2 study of durvalumab monotherapy and in combination with tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS study
    Meeting Abstract

    O'Reilly, E. M.; Oh, D. Y.; Dhani, N.; Renouf, D. J.; Lee, M. A.; Sun, W.; Fisher, G. A.; Hezel, A. F.; Chang, S. C.; Vlahovic, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective analysis of somatic and germline genetic alterations in patients with ampullary carcinomas
    Meeting Abstract

    Wong, W.; O'Reilly, E. M.; Varghese, A. M.; Yu, K. H.; Iacobuzio-Donahue, C. A.; Shia, J.; Klimstra, D.; Allen, P. J.; Lowery, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Tsui, D.; Lowery, M. A.; Capanu, M.; Yu, K. H.; Kelsen, D. P.; Gedvilaite, E.; Zhang, L.; Selcuklu, S. D.; You, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase I dose escalation study of 177Lu-HuMab-5B1 (MVT-1075) in combination with MVT-5873 as radioimmunotherapy (RIT) in subjects with relapsed / refractory pancreatic cancer or other CA19-9+malignancies
    Meeting Abstract

    O'Reilly, E. A.; Lohrmann, C.; O'Donoghue, J. A.; Borazanci, E.; Estrella, H.; Teng, R.; Melink, T.; Dorr, K.; Kearns, C.; Peterson, M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Rivaroxaban thromboprophylaxis in high risk ambulatory cancer patients receiving systemic therapy: Results of a randomized clinical trial (CASSINI)
    Meeting Abstract

    Khorana, A. A.; Soff, G. A.; Kakkar, A. K.; Vadhan-Raj, S.; Riess, H.; Wun, T.; Streiff, M. B.; Garcia, D. A.; Liebman, H. A.; Belani, C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save